TRICARE Science: Proven vs. Experimental Coverage

*Note: TRICARE.com is an independent reference site and is not affiliated with the Department of Defense or the official TRICARE program. For official policy, visit TRICARE.mil.*

## Quick answer In the context of TRICARE, "science" refers to the evidentiary standards the Defense Health Agency (DHA) uses to determine which treatments are "proven" and which are "experimental." TRICARE only covers medical services and supplies that are scientifically validated by peer-reviewed literature and regulatory bodies like the FDA.

## In detail TRICARE does not cover every new medical breakthrough. To be a covered benefit, a treatment must be proven safe and effective through the "Hierarchy of Evidence." This scientific scrutiny ensures that taxpayer funds are spent on reliable care and that service members are not subjected to unproven risks.

### The Standard for "Proven" Care For a procedure or drug to move from "experimental/investigational" to "covered," it must generally meet these scientific criteria: * **FDA Approval:** Drugs and devices must be cleared or approved by the U.S. Food and Drug Administration for the specific indication being treated. * **Peer-Reviewed Literature:** TRICARE reviewers look for published results from well-designed clinical trials in major medical journals (e.g., The Lancet, JAMA). * **National Medical Associations:** Endorsements from groups like the American Medical Association (AMA) or American College of Surgeons are heavily weighted.

### TRICARE Science and the T-5 Contract As of May 2026, scientific medical reviews and authorizations are managed by regional contractors: * **East Region:** Humana Military. * **West Region:** TriWest Healthcare Alliance. These contractors employ medical directors who apply TRICARE’s scientific policies to individual claims.

### Laboratory Developed Tests (LDTs) and Genomics TRICARE has a specific "Provisional Coverage Program" (PCP) for certain scientific advancements that show promise but haven't yet met the full "proven" threshold. This is common in genomic testing and precision medicine. This program allows for temporary coverage while scientific data is still being gathered.

### 2026 Cost Shares for Scientific Testing If a scientific test (like a diagnostic biopsy or blood panel) is deemed medically necessary and "proven," the cost depends on your plan:

## Who this applies to * **Active Duty Service Members (ADSMs):** Specifically regarding experimental treatments that may impact readiness or deployability. * **Retirees and Families:** When seeking "cutting-edge" treatments or off-label uses of drugs that TRICARE may deny as scientifically unproven. * **Cancer Patients:** Those seeking advanced genomic sequencing or participation in Phase II/III clinical trials. * **Providers:** Doctors must submit scientific justification when requesting "non-covered" or "experimental" procedures through the authorization process.

## Common scenarios **Scenario 1: The Off-Label Prescription** An Army retiree in Florida is prescribed a drug for an autoimmune condition, but the drug is only FDA-approved for cancer. Express Scripts denies the claim because the "science" for this specific use is not yet proven. The retiree must work with their doctor to provide peer-reviewed journals to Humana Military to appeal for an "off-label" exception.

**Scenario 2: Genomic Cancer Testing** A Navy spouse in San Diego is diagnosed with an aggressive tumor. Her oncologist wants a highly specific genetic panel to target treatment. Because this falls under TRICARE’s scientific "Provisional Coverage Program," TriWest approves the $3,000 test with a standard $0 copay (Prime) because the science, while new, meets the DHA’s temporary evidentiary standard.

**Scenario 3: Clinical Trials** A member wants to join a Phase I clinical trial for a new heart device. TRICARE generally denies this because Phase I trials are "investigational." The member would be responsible for 100% of the costs unless the trial is specifically sponsored by the NCI (National Cancer Institute) and meets strict 2026 TRICARE guidelines for oncology trials.

## Related terms * **Experimental/Investigational:** A status assigned to treatments that lack sufficient scientific evidence to be considered "proven" by TRICARE Standards. * **Medically Necessary:** Care that is appropriate, reasonable, and required for the diagnosis or treatment of an illness or injury. * **Provisional Coverage:** A temporary TRICARE benefit for emerging scientific treatments that are still in the data-collection phase. * **Hierarchy of Evidence:** The ranked order of scientific study types used to determine medical efficacy, with Meta-Analyses at the top. * **Peer-Reviewed:** Research that has been evaluated by independent experts in the same field before being published.

## Sources * **TRICARE.mil - Covered Services:** https://www.tricare.mil/CoveredServices/IsItCovered * **DHA - Procedures for Evaluating Medical Technologies:** https://health.mil/Reference-Center/Policies * **Humana Military (East):** https://www.humanamilitary.com/ * **TriWest Healthcare Alliance (West):** https://www.triwest.com/